Results 121 to 130 of about 1,727,469 (168)

Emergence of vaccine-derived poliovirus strains from the novel oral polio vaccine in the Central African Republic. [PDF]

mBio
Doté JW, Joffret M-L, Mazitchi A, Klapsa D, Kouatcho G, Kalthan E, Jouvenet N, Martin J, Gouandjika-Vasilache I, Bessaud M.   +9 more
europepmc   +1 more source

Immunogenicity and safety of novel oral polio vaccine type 2 (nOPV2) in pediatric populations: a systematic review and Bayesian meta-analysis. [PDF]

BMC Infect Dis
Boene JL, Campos LR, Carpi GC, Muhawenimana M, Machado SH, de Deus N, Bauhofer AFL.   +6 more
europepmc   +1 more source

Stopping Oral Polio Vaccine (OPV) After Defeating Poliomyelitis in Low- and Middle-Income Countries: Harmful Unintended Consequences? Review of the Nonspecific Effects of OPV. [PDF]

Open Forum Infect Dis, 2022
Aaby P, Nielsen S, Fisker AB, Pedersen LM, Welaga P, Hanifi SMA, Martins CL, Rodrigues A, Chumakov K, Benn CS.   +9 more
europepmc   +1 more source

Evaluation of the safety, immunogenicity, and faecal shedding of novel oral polio vaccine type 2 in healthy newborn infants in Bangladesh: a randomised, controlled, phase 2 clinical trial. [PDF]

Lancet, 2023
Zaman K, Bandyopadhyay AS, Hoque M, Gast C, Yunus M, Jamil KM, Mainou BA, Konopka-Anstadt JL, Hendley WS, Vincent A, Clemens R, Clemens SAC, Ross AG, Clemens JD, Tritama E.   +14 more
europepmc   +1 more source

Progress in Access and Oral Polio Vaccine Coverage Among Children Aged <5 Years in Polio Campaigns After the Political Change in Afghanistan. [PDF]

J Infect Dis
Sabawoon W, Seino S, Pason BM, Momin NWS, Kanamori S, Bender C, Takemura K.   +6 more
europepmc   +1 more source

[News Clip: Polio vaccine]

, 1964
Video footage from the WBAP-TV station in Fort Worth, Texas to accompany a news story about the Type Three Oral Polio Vaccine, which is supposed to offer the recipient life-long protection against the ...
WBAP-TV (Television station : Fort Worth, Tex.)
core  

Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine viruses. [PDF]

NPJ Vaccines, 2021
Wahid R, Mercer L, Macadam A, Carlyle S, Stephens L, Martin J, Chumakov K, Laassri M, Petrovskaya S, Smits SL, Stittelaar KJ, Gast C, Weldon WC, Konopka-Anstadt JL, Steven Oberste M, Van Damme P, De Coster I, Rüttimann R, Bandyopadhyay A, Konz J.   +19 more
europepmc   +1 more source

Adverse Events Following Immunization with Novel Oral Polio Vaccine Type 2, and the Experience and Challenges of Reporting in Sierra Leone [Letter]. [PDF]

Drug Healthc Patient Saf
Rahman NE.
europepmc   +1 more source

Environmental Surveillance for Risk Assessment in the Context of a Phase 2 Clinical Trial of Type 2 Novel Oral Polio Vaccine in Panama. [PDF]

Viruses, 2021
Rojas-Bonilla M, Coulliette-Salmond A, Belgasmi H, Wong K, Sayyad L, Vega E, Grimoldi F, Oberste MS, Rüttimann R.   +8 more
europepmc   +1 more source

Adverse Events Following Immunization with Novel Oral Polio Vaccine Type 2, and the Experience and Challenges of Reporting in Sierra Leone [Response to Letter]. [PDF]

Drug Healthc Patient Saf
Thomas F, Abiri OT, Kallon JM, Kangbai DM, Conteh TA, Conteh SM, Samuels EG, Awodele O.   +7 more
europepmc   +1 more source